GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 348 filers reported holding GLOBUS MED INC in Q4 2020. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,097,127 | +26.3% | 344,354 | +51.5% | 0.02% | +33.3% |
| Q2 2023 | $13,533,620 | +105277.4% | 227,303 | +0.2% | 0.02% | -6.2% |
| Q1 2023 | $12,843 | -23.6% | 226,752 | +0.2% | 0.02% | -30.4% |
| Q4 2022 | $16,810 | -99.9% | 226,335 | +2.8% | 0.02% | +15.0% |
| Q3 2022 | $13,117,000 | +6.4% | 220,200 | +0.2% | 0.02% | +11.1% |
| Q2 2022 | $12,331,000 | -14.3% | 219,654 | +12.7% | 0.02% | -5.3% |
| Q1 2022 | $14,386,000 | -0.2% | 194,979 | -2.4% | 0.02% | +5.6% |
| Q4 2021 | $14,420,000 | -2.5% | 199,718 | +3.5% | 0.02% | -10.0% |
| Q3 2021 | $14,787,000 | -3.8% | 192,997 | -2.7% | 0.02% | 0.0% |
| Q2 2021 | $15,374,000 | +24.6% | 198,298 | -0.9% | 0.02% | +17.6% |
| Q1 2021 | $12,335,000 | -5.9% | 200,022 | -0.4% | 0.02% | -5.6% |
| Q4 2020 | $13,102,000 | +31.9% | 200,888 | +0.1% | 0.02% | +12.5% |
| Q3 2020 | $9,934,000 | +1.5% | 200,604 | -2.2% | 0.02% | 0.0% |
| Q2 2020 | $9,791,000 | -1.8% | 205,219 | -12.4% | 0.02% | -23.8% |
| Q1 2020 | $9,968,000 | -29.2% | 234,377 | -2.0% | 0.02% | -12.5% |
| Q4 2019 | $14,088,000 | +16.0% | 239,274 | +0.7% | 0.02% | +9.1% |
| Q3 2019 | $12,143,000 | +19.2% | 237,548 | -1.4% | 0.02% | +15.8% |
| Q2 2019 | $10,187,000 | -11.0% | 240,823 | +3.9% | 0.02% | -13.6% |
| Q1 2019 | $11,447,000 | +15.2% | 231,678 | +0.9% | 0.02% | 0.0% |
| Q4 2018 | $9,940,000 | +28.9% | 229,678 | +69.0% | 0.02% | +46.7% |
| Q3 2018 | $7,713,000 | +7.1% | 135,891 | -4.8% | 0.02% | 0.0% |
| Q2 2018 | $7,202,000 | +3.6% | 142,732 | +2.2% | 0.02% | 0.0% |
| Q1 2018 | $6,955,000 | +12.0% | 139,601 | -7.6% | 0.02% | +15.4% |
| Q4 2017 | $6,212,000 | +35.6% | 151,138 | -1.9% | 0.01% | +30.0% |
| Q3 2017 | $4,581,000 | -3.7% | 154,127 | +7.4% | 0.01% | -9.1% |
| Q2 2017 | $4,755,000 | +12.9% | 143,448 | +0.9% | 0.01% | +10.0% |
| Q1 2017 | $4,213,000 | +26.1% | 142,236 | +5.7% | 0.01% | +25.0% |
| Q4 2016 | $3,340,000 | +99.8% | 134,620 | +81.7% | 0.01% | +60.0% |
| Q3 2016 | $1,672,000 | -4.6% | 74,078 | +0.7% | 0.01% | 0.0% |
| Q2 2016 | $1,753,000 | +5.9% | 73,563 | +5.6% | 0.01% | 0.0% |
| Q1 2016 | $1,655,000 | -13.0% | 69,670 | +1.9% | 0.01% | -16.7% |
| Q4 2015 | $1,902,000 | +44.5% | 68,365 | +7.3% | 0.01% | +50.0% |
| Q3 2015 | $1,316,000 | -16.9% | 63,695 | +3.3% | 0.00% | -20.0% |
| Q2 2015 | $1,583,000 | +0.6% | 61,664 | -1.0% | 0.01% | 0.0% |
| Q1 2015 | $1,573,000 | +26.1% | 62,304 | +18.7% | 0.01% | +25.0% |
| Q4 2014 | $1,247,000 | +16.5% | 52,479 | -3.5% | 0.00% | +33.3% |
| Q3 2014 | $1,070,000 | -24.2% | 54,375 | -7.9% | 0.00% | -25.0% |
| Q2 2014 | $1,412,000 | +8.4% | 59,045 | +20.6% | 0.00% | 0.0% |
| Q1 2014 | $1,302,000 | +23.6% | 48,973 | -6.1% | 0.00% | +33.3% |
| Q4 2013 | $1,053,000 | +18.8% | 52,163 | +2.8% | 0.00% | 0.0% |
| Q3 2013 | $886,000 | +9.7% | 50,733 | +5.9% | 0.00% | 0.0% |
| Q2 2013 | $808,000 | – | 47,924 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 589,100 | $45,137,000 | 24.71% |
| Sterling Investment Advisors, Ltd. | 188,123 | $14,414,000 | 4.29% |
| Godshalk Welsh Capital Management, Inc. | 73,748 | $5,651,000 | 3.52% |
| Pembroke Management, LTD | 601,447 | $46,083,000 | 3.47% |
| Integral Health Asset Management, LLC | 150,000 | $11,493,000 | 3.30% |
| XXEC, Inc. | 51,925 | $3,978,000 | 3.03% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 615,000 | $47,122,000 | 2.42% |
| Van Berkom & Associates Inc. | 946,997 | $72,559,000 | 2.20% |
| RTW INVESTMENTS, LP | 1,670,811 | $128,018,000 | 1.93% |
| Sivik Global Healthcare LLC | 95,000 | $7,279,000 | 1.74% |